Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - INTEREST INCOME & EXPENSE
Interest Income & Expense RPRX - Royalty Pharma plc
187 M
LAST VALUE
6.14%
2 YEAR CAGR
-7.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR